The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients with airway obstruction such as photodynamic therapy, airway stenting, radiotherapy, laser therapy, and cryotherapy, can be done with or without the guidance of bronchoscopy. Airway stent is achieving durable airway patency that results in the length of life span in patients with lung cancer and improvement of quality.
(Get 15% Discount on Buying this Report)
Get Report Sample Copy @
https://www.omrglobal.com/request-sample/airway-stent-lung-stent-market
The tracheobronchial stent is a device utilized to fragment narrowed airway open. The narrowed airway results from lung cancer, infections, abnormal granulation tissue, metastatic cancer, lymphoma, and tuberculosis. The advantages of tracheobronchial stents include rigidity, the body of the stent enables resist compression from the airway tissue and allow airways to remain open and keep the lung from becoming cracked which is driving the growth of tracheobronchial stents market. It is used in the palliation of lung cancer to maintain patency of reopened airway to secure extrinsically compressed central airway. Airway stent placement is a treatment option with not for isolation of bleeding source but for the maintenance of the airway.
A Full Report is Available at:
https://www.omrglobal.com/industry-reports/airway-stent-lung-stent-market
Airway obstruction owing to lung cancer from non-bronchial can produce distressing breathlessness and life-threatening for acute presenting symptoms of diseases or when occurred after other treatments. Expandable metallic stents are used successfully to relieve airway obstruction in patients. Malignant airway obstructions are common in lung patients and it is utilized to preserve airway in malignant airway obstruction. Hemoptysis is managed by different methods such as bronchoscopy intervention, surgery, endobronchial tamponade, embolization, and conservative treatment. Thus, the factors include the rising prevalence of lung cancer, increasing the aging population, rising incidence of chronic respiratory diseases and rising healthcare industry is propelling the growth of the airway stent/lung stent market.

Global Airway Stent/Lung Stent Market- Segmentation

By Type

Tracheobronchial Stents
Laryngeal stents
By Material

Metallic Stents
Silicone Stents
Hybrid Stents
By End-User

Hospitals
Free-Standing Clinics/Ambulatory Surgical Centers
Global Airway Stent/Lung Stent Market– Segment by Region

North America

US
Canada
Europe

Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific

China
Japan
India
Rest of Asia-Pacific
Rest of the World
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @
https://www.omrglobal.com/report-customization/airway-stent-lung-stent-market

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404